These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30540740)

  • 21. A Cloning-Free Method for CRISPR/Cas9-Mediated Genome Editing in Fission Yeast.
    Zhang XR; He JB; Wang YZ; Du LL
    G3 (Bethesda); 2018 May; 8(6):2067-2077. PubMed ID: 29703785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of site-specific mutant mice using the CRISPR/Cas9 system.
    Bai M; Li Q; Shao YJ; Huang YH; Li DL; Ma YL
    Yi Chuan; 2015 Oct; 37(10):1029-35. PubMed ID: 26496755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TALEN-Mediated Mutagenesis and Genome Editing.
    Ma AC; Chen Y; Blackburn PR; Ekker SC
    Methods Mol Biol; 2016; 1451():17-30. PubMed ID: 27464798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides.
    Bialk P; Sansbury B; Rivera-Torres N; Bloh K; Man D; Kmiec EB
    Sci Rep; 2016 Sep; 6():32681. PubMed ID: 27609304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient SSA-mediated precise genome editing using CRISPR/Cas9.
    Li X; Bai Y; Cheng X; Kalds PGT; Sun B; Wu Y; Lv H; Xu K; Zhang Z
    FEBS J; 2018 Sep; 285(18):3362-3375. PubMed ID: 30085411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA.
    Richardson CD; Ray GJ; DeWitt MA; Curie GL; Corn JE
    Nat Biotechnol; 2016 Mar; 34(3):339-44. PubMed ID: 26789497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous sequence patterns predispose the repair modes of CRISPR/Cas9-induced DNA double-stranded breaks in Arabidopsis thaliana.
    Vu GTH; Cao HX; Fauser F; Reiss B; Puchta H; Schubert I
    Plant J; 2017 Oct; 92(1):57-67. PubMed ID: 28696528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair.
    Gutschner T; Haemmerle M; Genovese G; Draetta GF; Chin L
    Cell Rep; 2016 Feb; 14(6):1555-1566. PubMed ID: 26854237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome Editing in Mouse Embryos with CRISPR/Cas9.
    Scott GJ; Gruzdev A
    Methods Mol Biol; 2019; 1960():23-40. PubMed ID: 30798518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in the application of CRISPR: From gene to base editing.
    Wu W; Yang Y; Lei H
    Med Res Rev; 2019 Mar; 39(2):665-683. PubMed ID: 30171624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous precise editing of multiple genes in human cells.
    Riesenberg S; Chintalapati M; Macak D; Kanis P; Maricic T; Pääbo S
    Nucleic Acids Res; 2019 Nov; 47(19):e116. PubMed ID: 31392986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 34. CRISPR/Cas9-Induced Breaks in Heterochromatin, Visualized by Immunofluorescence.
    Mitrentsi I; Soutoglou E
    Methods Mol Biol; 2021; 2153():439-445. PubMed ID: 32840797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
    Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
    Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designed nucleases for targeted genome editing.
    Lee J; Chung JH; Kim HM; Kim DW; Kim H
    Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of eukaryotic chromatin state on CRISPR-Cas9 editing efficiencies.
    Verkuijl SA; Rots MG
    Curr Opin Biotechnol; 2019 Feb; 55():68-73. PubMed ID: 30189348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.
    Maruyama T; Dougan SK; Truttmann MC; Bilate AM; Ingram JR; Ploegh HL
    Nat Biotechnol; 2015 May; 33(5):538-42. PubMed ID: 25798939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic evaluation of CRISPR-Cas systems reveals design principles for genome editing in human cells.
    Wang Y; Liu KI; Sutrisnoh NB; Srinivasan H; Zhang J; Li J; Zhang F; Lalith CRJ; Xing H; Shanmugam R; Foo JN; Yeo HT; Ooi KH; Bleckwehl T; Par YYR; Lee SM; Ismail NNB; Sanwari NAB; Lee STV; Lew J; Tan MH
    Genome Biol; 2018 May; 19(1):62. PubMed ID: 29843790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair.
    Jasin M; Haber JE
    DNA Repair (Amst); 2016 Aug; 44():6-16. PubMed ID: 27261202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.